Impact of Adding Jones Technique to Mulligan Therapy in Patients With Cervicogenic Headache

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorCairo University

About this trial

this study will be conducted to investigate impact of adding jones technique to mulligan therapy in patients with cervicogenic headache

Eligibility criteria

Qualifiers

20 to 60 years old patient with unilaterally of the head pain

pain triggered by external pressure over the upper cervical joints (c1-c3)

pain elicited by the neck movements, and/or sustained awkward positions with reduced neck ROM

headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)

Disqualifiers

Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.

Prolonged history of steroid use.

Resting blood pressure greater than 140/90 mmhg.

cervical spinal stenosis, diminished sensation and central nervous system involvement,

Trial design

Treatments tested in this trial

  • jones and mulligan therapy
  • mulligan therapy
  • exercises program

Treatment groups

90 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators